- Tytuł:
- A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532)
- Autorzy:
- Źródło:
- European Urology Oncology; 20240101, Issue: Preprints
Periodyk